JP2008534562A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534562A5
JP2008534562A5 JP2008503576A JP2008503576A JP2008534562A5 JP 2008534562 A5 JP2008534562 A5 JP 2008534562A5 JP 2008503576 A JP2008503576 A JP 2008503576A JP 2008503576 A JP2008503576 A JP 2008503576A JP 2008534562 A5 JP2008534562 A5 JP 2008534562A5
Authority
JP
Japan
Prior art keywords
composition
composition according
bioadhesion
weight
carrier particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008503576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534562A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2006/001115 external-priority patent/WO2006103407A2/en
Publication of JP2008534562A publication Critical patent/JP2008534562A/ja
Publication of JP2008534562A5 publication Critical patent/JP2008534562A5/ja
Pending legal-status Critical Current

Links

JP2008503576A 2005-03-28 2006-03-28 偏頭痛の治療に有用な新しい製薬組成物 Pending JP2008534562A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66537805P 2005-03-28 2005-03-28
PCT/GB2006/001115 WO2006103407A2 (en) 2005-03-28 2006-03-28 New pharmaceutical compositions useful in the treatment of migraine

Publications (2)

Publication Number Publication Date
JP2008534562A JP2008534562A (ja) 2008-08-28
JP2008534562A5 true JP2008534562A5 (enExample) 2009-05-21

Family

ID=34956743

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503576A Pending JP2008534562A (ja) 2005-03-28 2006-03-28 偏頭痛の治療に有用な新しい製薬組成物

Country Status (4)

Country Link
US (1) US20090232898A1 (enExample)
EP (1) EP1863454A2 (enExample)
JP (1) JP2008534562A (enExample)
WO (1) WO2006103407A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
EP2240022B1 (en) * 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
US20110082150A1 (en) * 2008-02-11 2011-04-07 Robert Owen Cook Headache pre-emption by dihydroergotamine treatment during headache Precursor events
US20110118189A1 (en) * 2008-04-28 2011-05-19 Farr Stephen J Novel formulations for treatment of migraine
AU2013202680C1 (en) * 2008-04-28 2016-06-23 Zogenix, Inc. Novel formulations for treatment of migraine
EP2299982B1 (de) * 2008-06-20 2018-04-04 Merck Patent GmbH Direkt verpressbare und schnell zerfallende tablettenmatirx
WO2010097703A1 (en) * 2009-02-25 2010-09-02 Actavis Group Ptc Ehf Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
US20120294937A1 (en) 2009-12-29 2012-11-22 Novartis Ag New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
US20140073678A1 (en) * 2012-09-12 2014-03-13 Monosol Rx, Llc Anti-pain and anti-nausea and/or vomiting combinatorial compositions
EP2935280A4 (en) 2012-12-21 2016-05-25 Map Pharmaceuticals Inc 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS
BR112017004552A2 (pt) * 2014-09-09 2017-12-05 Charleston Laboratories Inc composições farmacêuticas
EP3316865A4 (en) 2015-07-02 2019-01-23 Civitas Therapeutics, Inc. TRIPTAN POWDER FOR PULMONARY ADMINISTRATION
US20170131689A1 (en) * 2015-11-06 2017-05-11 International Business Machines Corporation Communication of physical scents and scent representations
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2019155389A1 (en) * 2018-02-06 2019-08-15 Target Oncology Inc. An aqueous mucoadhesive and bioadhesive composition for the treatment
KR20220008824A (ko) 2019-04-17 2022-01-21 컴퍼스 패쓰파인더 리미티드 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800080L (sv) * 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) * 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine

Similar Documents

Publication Publication Date Title
US6358991B2 (en) Methods of treating neuropeptide Y-related conditions
US20090068262A1 (en) Rapid dissolution of combination products
US20020019433A1 (en) Methods of treating excessive intraocular pressure
US20020028805A1 (en) Methods of inhibiting uterotrophic effects of estrogenic agents
CN1326340A (zh) 用于治疗急性疾病的药用组合物
JP2004269545A (ja) 急性疼痛の処置のためのフェンタニル組成物
JP2008534564A5 (enExample)
JP2012513955A5 (enExample)
HU202746B (en) Process for producing pharmaceutical composition comprising terfenadine/ibuprofen combination
JP2004502730A (ja) ビスホスホネート、エストロゲン剤および所望によるエストロゲンの組み合わせ
JP2006527195A (ja) トリプタンおよびｎｓａｉｄを含む組成物
JP2008534562A (ja) 偏頭痛の治療に有用な新しい製薬組成物
CN102088966B (zh) 药物制剂
JP2015528504A5 (enExample)
WO2008124081A2 (en) Rapid dissolution of combination products
WO2014142607A1 (ko) 약제학적 복합제제
JP2008534563A5 (enExample)
JP2005503382A5 (enExample)
JP2008517988A5 (enExample)
WO2008101375A1 (en) A gastric retentive sustained-release pharmaceutical composition comprising irbesartan
WO2012060786A2 (en) Cefpodoxime proxetil formulations comprising viscosity agent
US20100008986A1 (en) Pharmaceutical compositions comprising sumatriptan and naproxen
US6376486B1 (en) Methods of inhibiting sphincter incontinence
JP3784084B2 (ja) 医薬用錠剤
US20020019373A1 (en) Combinations of bisphosphonates and estrogenic agents